These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

366 related articles for article (PubMed ID: 32033229)

  • 61. Chelation of lead with DMPS and BAL in rats injected with lead.
    Twarog TA; Cherian MG
    Bull Environ Contam Toxicol; 1983 Feb; 30(2):165-9. PubMed ID: 6839041
    [No Abstract]   [Full Text] [Related]  

  • 62. Chronic arsenic poisoning.
    Hall AH
    Toxicol Lett; 2002 Mar; 128(1-3):69-72. PubMed ID: 11869818
    [TBL] [Abstract][Full Text] [Related]  

  • 63. Nanoencapsulation of DMSA monoester for better therapeutic efficacy of the chelating agent against arsenic toxicity.
    Yadav A; Mathur R; Samim M; Lomash V; Kushwaha P; Pathak U; Babbar AK; Flora SJ; Mishra AK; Kaushik MP
    Nanomedicine (Lond); 2014 Apr; 9(4):465-81. PubMed ID: 24910877
    [TBL] [Abstract][Full Text] [Related]  

  • 64. Dithiol compounds at low concentrations increase arsenite toxicity.
    Jan KY; Wang TC; Ramanathan B; Gurr JR
    Toxicol Sci; 2006 Apr; 90(2):432-9. PubMed ID: 16421177
    [TBL] [Abstract][Full Text] [Related]  

  • 65. Insights on alpha lipoic and dihydrolipoic acids as promising scavengers of oxidative stress and possible chelators in mercury toxicology.
    Bjørklund G; Aaseth J; Crisponi G; Rahman MM; Chirumbolo S
    J Inorg Biochem; 2019 Jun; 195():111-119. PubMed ID: 30939378
    [TBL] [Abstract][Full Text] [Related]  

  • 66. DMPS-arsenic challenge test. I: Increased urinary excretion of monomethylarsonic acid in humans given dimercaptopropane sulfonate.
    Aposhian HV; Arroyo A; Cebrian ME; del Razo LM; Hurlbut KM; Dart RC; Gonzalez-Ramirez D; Kreppel H; Speisky H; Smith A; Gonsebatt ME; Ostrosky-Wegman P; Aposhian MM
    J Pharmacol Exp Ther; 1997 Jul; 282(1):192-200. PubMed ID: 9223554
    [TBL] [Abstract][Full Text] [Related]  

  • 67. Arsenic excretion after treatment of arsenic poisoning with DMSA or DMPS in mice.
    Maehashi H; Murata Y
    Jpn J Pharmacol; 1986 Jan; 40(1):188-90. PubMed ID: 3007828
    [TBL] [Abstract][Full Text] [Related]  

  • 68. Mercury binding to the chelation therapy agents DMSA and DMPS and the rational design of custom chelators for mercury.
    George GN; Prince RC; Gailer J; Buttigieg GA; Denton MB; Harris HH; Pickering IJ
    Chem Res Toxicol; 2004 Aug; 17(8):999-1006. PubMed ID: 15310232
    [TBL] [Abstract][Full Text] [Related]  

  • 69. Effect of chelating agents on biliary excretion of arsenic in perfused livers of guinea pigs pretreated with As2O3.
    Reichl FX; Kreppel H; Szinicz L; Muckter H; Fichtl B; Schumann K; Forth W
    Vet Hum Toxicol; 1990 Jun; 32(3):223-6. PubMed ID: 2353432
    [TBL] [Abstract][Full Text] [Related]  

  • 70. Inhibitory mechanism of dimercaptopropanesulfonic acid (DMPS) in the cellular biomethylation of arsenic.
    Wang S; Shi N; Geng Z; Li X; Hu X; Wang Z
    Biochimie; 2014 Nov; 106():167-74. PubMed ID: 25194983
    [TBL] [Abstract][Full Text] [Related]  

  • 71. Therapeutic efficacy of new dimercaptosuccinic acid (DMSA) analogues in acute arsenic trioxide poisoning in mice.
    Kreppel H; Paepcke U; Thiermann H; Szinicz L; Reichl FX; Singh PK; Jones MM
    Arch Toxicol; 1993; 67(8):580-5. PubMed ID: 7506906
    [TBL] [Abstract][Full Text] [Related]  

  • 72. Optical isomers of 2,3-dimercapto-1-propanesulfonate: antidotal activity, in vitro and in vivo, against sodium arsenite.
    Hsu CA; Aposhian HV; Heydolph S; Parr W
    J Pharmacol Exp Ther; 1983 Feb; 224(2):314-8. PubMed ID: 6687396
    [TBL] [Abstract][Full Text] [Related]  

  • 73. [Two different clinical cases of acute arsenic trioxide intoxication].
    Magdalan J; Smolarek M; Porebska B; Zawadzki M; Dyś P
    Przegl Lek; 2007; 64(4-5):336-8. PubMed ID: 17724905
    [TBL] [Abstract][Full Text] [Related]  

  • 74. Effects of combined administration of captopril and DMSA on arsenite induced oxidative stress and blood and tissue arsenic concentration in rats.
    Kalia K; Narula GD; Kannan GM; Flora SJ
    Comp Biochem Physiol C Toxicol Pharmacol; 2007 Jan; 144(4):372-9. PubMed ID: 17188940
    [TBL] [Abstract][Full Text] [Related]  

  • 75. Effect of various antidotes on biliary excretion of arsenic in isolated perfused livers of guinea pigs after acute experimental poisoning with As2O3.
    Reichl FX; Mückter H; Kreppel H; Forth W
    Pharmacol Toxicol; 1992 May; 70(5 Pt 1):352-6. PubMed ID: 1608923
    [TBL] [Abstract][Full Text] [Related]  

  • 76. Beneficial effect of combined administration of some naturally occurring antioxidants (vitamins) and thiol chelators in the treatment of chronic lead intoxication.
    Flora SJ; Pande M; Mehta A
    Chem Biol Interact; 2003 Jun; 145(3):267-80. PubMed ID: 12732454
    [TBL] [Abstract][Full Text] [Related]  

  • 77. Monoisoamyl 2,3-dimercaptosuccinic acid attenuates arsenic induced toxicity: behavioral and neurochemical approach.
    Ram Kumar M; Flora SJ; Reddy GR
    Environ Toxicol Pharmacol; 2013 Jul; 36(1):231-42. PubMed ID: 23644418
    [TBL] [Abstract][Full Text] [Related]  

  • 78. British anti-Lewisite. II. Dithiols as antidotes.
    PETERS RA
    J R Inst Public Health; 1952 May; 15(5):122-39. PubMed ID: 14918251
    [No Abstract]   [Full Text] [Related]  

  • 79. Intentional overdose of dimercaptosuccinic acid in the course of treatment for arsenic poisoning.
    Buchwald AL
    J Toxicol Clin Toxicol; 2001; 39(1):113-4. PubMed ID: 11327220
    [No Abstract]   [Full Text] [Related]  

  • 80. The use of haemodialysis and 2,3 propanesulphonate (DMPS) to manage acute oral poisoning by lethal dose of arsenic trioxide.
    Kruszewska S; Wiese M; Kołaciński Z; Mielczarska J
    Int J Occup Med Environ Health; 1996; 9(2):111-5. PubMed ID: 8803325
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 19.